Styria as a Visionary and Pioneer in the Field of Life Sciences
The unique combination of a good educational system, excellent universities and non-university research institutions along with a diverse economy makes Styria an internationally leading research location. The smooth transition from the idea to implementation enables research results to be put into practice earlier, and thus frequently in a more cost-efficient manner for the benefit of the client. Cost advantages and quicker market launches comprise a competitive edge, especially for companies in the pharmaceutical industry or the field of medical engineering. This is because the challenge facing firms in a dynamic and steadily changing market is to assert themselves on the market time and again.
Companies conducting research can also rely on an exceptionally good infrastructure. Universities and research facilities are investing to expand their own capacities and services. This commitment to the future and their own capabilities is demonstrated, for example, by the pilot plant of RCPE GmbH, a COMET research center of the Graz University of Technology, the University of Graz and Joanneum Research Forschungsgesellschaft, the world’s only research institution for pharmaceutical production processes up to the hazard category OEB 4 on the Inffeldgasse Campus of the Graz University of Technology.
To develop a “real” innovation from an idea also involves translating the idea into reality. The Styria research institutions are supported by a large number of regional and international partners. In addition to market leaders such as Anton Paar, AVL, ZETA and Andritz, many small and medium-sized companies are also involved in research. These firms not only complement the skills of our researchers but enrich research projects by supplying news perspectives and solutions based on their longstanding experience.
This close cooperation encompassing research, business and industry is anything but accidental. The provincial government and their business promotion and funding agencies recognized the opportunities and possibilities opened up by the field of life sciences early on, and support various programs and initiatives designed to link knowledge holders and decision makers. This commitment pays off. The 28,000 employees in the sector already account for about EUR 3 billion in revenue.